FAPI PET Signal in Hibernoma Reflects FAP Expression in Tumor Vasculature Cells.


Journal

Clinical nuclear medicine
ISSN: 1536-0229
Titre abrégé: Clin Nucl Med
Pays: United States
ID NLM: 7611109

Informations de publication

Date de publication:
01 Jul 2023
Historique:
medline: 7 6 2023
pubmed: 5 5 2023
entrez: 5 5 2023
Statut: ppublish

Résumé

A 43-year-old man with a growing mass in the right groin, concerned for liposarcoma, underwent MRI and 68 Ga-fibroblast activation protein inhibitor (FAPI)-46 PET/CT before surgery. Fibroblast activation protein inhibitor PET/CT demonstrated increased uptake (SUV max , 3.2) predominantly in the solid portion, where MRI showed gadolinium enhancement. The patient subsequently underwent surgery and was diagnosed with hibernoma. The immunohistochemistry of the tumor revealed the fibroblast activation protein expression in the fibrovascular network and myofibroblastic cells of the tumor. This case suggests that the FAPI uptake can be affected by the vascular cells, and thus, a careful interpretation of the FAPI PET signal may be needed.

Identifiants

pubmed: 37146173
doi: 10.1097/RLU.0000000000004689
pii: 00003072-202307000-00037
doi:

Substances chimiques

Contrast Media 0
Gadolinium AU0V1LM3JT
Gallium Radioisotopes 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e353-e355

Informations de copyright

Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest and sources of funding: J.C. is the recipient of grants from the ERF-SNMMI (2019–2021 Molecular Imaging Research Grant for Junior Academic Faculty), the Philippe Foundation Inc (New York), and the ARC Foundation (France) (International Mobility Award SAE20160604150). J.C. is a consultant for Blue Earth Diagnostics, Curium Pharma, GE Healthcare, Janssen Pharmaceuticals, Progenics Radiopharmaceuticals, Radiomedix, and Telix Pharmaceuticals, outside of the submitted work. The study was partially funded by the ERF- SNMMI (2019–2021 Molecular Imaging Research Grant for Junior Academic Faculty). All other coauthors have no conflict of interest.

Références

Elqatni M, Ghafir D. Images in clinical medicine. Hibernoma of the neck. N Engl J Med . 2012;367:1636.
Furlong MA, Fanburg-Smith JC, Miettinen M. The morphologic spectrum of hibernoma: a clinicopathologic study of 170 cases. Am J Surg Pathol . 2001;25:809–814.
Richard D, Picard F. Brown fat biology and thermogenesis. Front Biosci (Landmark Ed) . 2011;16:1233–1260.
Pothen L, D'Abadie P, Kozyreff A, et al. Hibernoma mimicking liposarcoma. Lancet . 2018;392:244.
Kalluri R. The biology and function of fibroblasts in cancer. Nat Rev Cancer . 2016;16:582–598.
Koczorowska MM, Tholen S, Bucher F, et al. Fibroblast activation protein-α, a stromal cell surface protease, shapes key features of cancer associated fibroblasts through proteome and degradome alterations. Mol Oncol . 2016;10:40–58.
Mona CE, Benz MR, Hikmat F, et al. Correlation of (68)Ga-FAPI-46 PET biodistribution with FAP expression by immunohistochemistry in patients with solid cancers: interim analysis of a prospective translational exploratory study. J Nucl Med . 2022;63:1021–1026.
Fitzgerald AA, Weiner LM. The role of fibroblast activation protein in health and malignancy. Cancer Metastasis Rev . 2020;39:783–803.

Auteurs

Masatoshi Hotta (M)

From the Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology.

Christine E Mona (CE)

From the Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology.

Joseph G Crompton (JG)

Division of Surgical-Oncology, Department of Surgery.

Wesley R Armstrong (WR)

From the Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology.

Andrei Gafita (A)

From the Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology.

Scott D Nelson (SD)

Department of Pathology, University of California Los Angeles, Los Angeles, CA.

David W Dawson (DW)

Department of Pathology, University of California Los Angeles, Los Angeles, CA.

Jeremie Calais (J)

From the Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH